Interleukin Genetics exits NYSE for Pink OTC Markets

Interleukin Genetics Inc. (OTC: ILIU) is no longer traded on the New York Stock Exchange. The company transferred its common stock to the OTCQB marketplace because it could no longer meet NYSE listing requirements, though the recent quarter’s results improved.

This entry was posted in Genetics, Human Genetics. Bookmark the permalink.

Comments are closed.